| Dr Kameron Shea Zimin, DMD | |
|
528 Chief Eddie Hoffman Hwy, Bethel, AK 99559 | |
| (907) 543-6000 | |
| Not Available |
| Full Name | Dr Kameron Shea Zimin |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 528 Chief Eddie Hoffman Hwy, Bethel, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538658398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 132375 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kameron Shea Zimin, DMD Po Box 528, Bethel, AK 99559-0528 Ph: (907) 543-6000 | Dr Kameron Shea Zimin, DMD 528 Chief Eddie Hoffman Hwy, Bethel, AK 99559 Ph: (907) 543-6000 |
News Archive
Gem Pharmaceuticals announced today that the initial soft tissue sarcoma (STS) patients have been enrolled into the Company's Phase 2 clinical trial. This open-label study will assess the efficacy and safety of Gem's lead compound, GPX-150 (an investigational medication), in approximately 30 adults as first-line therapy for advanced or metastatic disease.
Kaiser Health News staff writer Chris Weaver reports on developments surrounding efforts in the Senate regarding legislation on Medicare payments to physicians. "Legislation to 'fix' Medicare's physician payment formula has stalled in the Senate, just days after Majority Leader Harry Reid, D-Nev., announced his intent to fast-track the measure.
Arpida Ltd. has announced that it has received approval from the US Food and Drug Administration for a Phase II trial with intravenous iclaprim in the treatment of patients with hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP) or healthcare-associated pneumonia (HCAP) suspected or confirmed to be due to Gram-positive pathogens.
Breast cancer is one of the most common cancers affecting American women and may lead to more than 38,000 deaths this year. Medical Doctor, Researcher and Cancer expert, Dr. Isaac Eliaz shares 8 simple tips during Breast Cancer Awareness Month, so you can learn more about treating and preventing breast cancer.
Seattle Genetics, Inc. today announced that its phase IIb clinical trial of lintuzumab (SGN-33) in older patients with acute myeloid leukemia (AML) did not meet its primary endpoint of extending overall survival. Lintuzumab is a naked monoclonal antibody that targets the CD33 antigen. As a result of the outcome of this trial, the company will discontinue its development program for lintuzumab.
› Verified 3 days ago
Dr. Dane Lenaker, D.M.D Dentist Medicare: Not Enrolled in Medicare Practice Location: 829 Chief Eddie Hoffman Highway, Bethel, AK 99559 Phone: 907-543-6212 Fax: 907-543-6393 | |
Dr. Evan Taizo Uyeda, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 185 Hoffman Rd, Bethel, AK 99559 Phone: 907-543-6000 | |
Dr. Matthew J West, DMD Dentist Medicare: Medicare Enrolled Practice Location: 829 Cheif Eddie Hoffman Hwy, Bethel, AK 99559 Phone: 907-543-6272 Fax: 907-543-6393 | |
Dr. Edwin Henry Allgair Jr., DDS Dentist Medicare: Medicare Enrolled Practice Location: 660 Third Ave Ste C, Bethel, AK 99559 Phone: 907-545-3996 | |
Dr. Joshua James Giauque, DMD MPH Dentist Medicare: Not Enrolled in Medicare Practice Location: 829 Chief Eddie Hoffman Hwy, Bethel, AK 99559 Phone: 907-543-6300 | |
Dr. Jill Kathryn Mclean, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 829 Chief Eddie Hoffman Hwy, Bethel, AK 98862 Phone: 907-543-6229 | |
Dr. Sadi Elena Saenz, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 829 Chief Eddie Hoffman Hwy, Bethel, AK 99559 Phone: 907-543-6000 |